Intrinsic Value of S&P & Nasdaq Contact Us

The Valens Company Inc. VLNS.TO TSX

Toronto Stock Exchan • Healthcare • Drug Manufacturers - Specialty & Generic • CA • CAD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Financial Health Score — VLNS.TO

The Valens Company Inc. (VLNS.TO) has an overall financial health rating of B+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-01-18.

B+
Overall Rating
2023-01-18

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2023-01-18 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-17 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-16 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-13 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-12 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-11 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-10 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-09 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-06 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-05 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-04 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-01-03 B+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message